Abstract:1887 Purposes: Reduced capacity to repair mutagen-induced DNA damage is implicated in susceptibility to cancer development. The nicotine-derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced lung adenocarcinogen through formation of DNA adducts. Methods: We used the comet assay to assess whether susceptibility to NNK-induced DNA damage was associated with increased risk of lung cancer in a hospital-based case-control study. We measured baseline and NNK-induced DNA damage in peripheral blood lymphocyte assays from 401 previously untreated Caucasian lung cancer cases and 388 matched healthy controls. DNA damage using NNK as the mutagen challenge was visualized with the comet assay and quantified by the Olive tail moment parameter. Multivariable analysis was used to assess risks for lung cancer associated with level of DNA damage. Results: The baseline levels of DNA damage were statistically significantly higher in cases than in controls (tail moments: 1.22±0.57 vs. 1.14±0.50, P =0.025), as were NNK-induced DNA damage (2.42±1.15 vs. 2.16±1.07, P =0.001). The net NNK-induced DNA damage (NNK-induced subtracted by baseline) was also significantly higher in cases compared with controls (1.20 vs. 1.03, P = 0.018). When data were dichotomized at the median value of olive tail moments in the controls and adjusted for age, sex, and smoking status, higher levels of net NNK-induced DNA damage were associated with a significantly increased lung cancer risk (odds ratio [OR] = 1.45, 95% CI = 1.09 to 1.94). In addition, there was also a significant dose effect. Compared to individuals in the lowest quartile of damage, the ORs for individuals in the second, third and fourth quartiles were 1.32 (95% CI: 0.86-2.03), 1.59 (95% CI: 1.04-2.43), and 1.78 (95% CI: 1.17-2.70), respectively (P-for trend =0.005). In stratified analysis, the elevated risk appeared to be higher in adenocarcinoma (OR=1.50, 95% CI: 1.05-2.13) than in other histologies (OR=1.38, 95% CI, 0.95-2.00), and higher in heavy smokers (OR=1.64, 95% CI: 1.09-2.47) than in light smokers (OR=1.49, 95% CI, 0.79-2.79). Conclusions: This is the first study to use NNK as a challenge mutagen in the comet assay. The results suggest that NNK-induced DNA damage is associated with an increased risk of lung adenocarcinoma and the net NNK-induced olive tail moment measure may serve as a useful predictor of lung cancer risk. Supported by NCI grants CA 55769, CA 70907 and CA 86390.

Targeting CD36 determines nicotine derivative NNK-induced lung adenocarcinoma carcinogenesis

Nicotine Enhances Invasion and Metastasis of Human Colorectal Cancer Cells Through the Nicotinic Acetylcholine Receptor Downstream P38 MAPK Signaling Pathway.

Activation of 5-Lipoxygenase is Required for Nicotine Mediated Epithelial-Mesenchymal Transition and Tumor Cell Growth

Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and β-adrenergic receptor signaling pathways

The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment

β2-Adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α.

4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone Promoted Gastric Cancer Growth Through Prostaglandin E Receptor (EP2 and EP4) in Vivo and in Vitro

Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1

CD36 Initiates Src Signal Transduction to Promote Actin Remodeling-Involved Metastasis of Lung Adenocarcinoma in High-Fat Environment

NNAL, a major metabolite of tobacco-specific carcinogen NNK, promotes lung cancer progression through deactivating LKB1 in an isomer-dependent manner

α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape.

Hypermethylation of the ADIRF promoter regulates its expression level and is involved in NNK-induced malignant transformation of lung bronchial epithelial cells

CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway

Upregulated DNMT3a coupling with inhibiting p62-dependent autophagy contributes to NNK tumorigenicity in human bronchial epithelial cells

LKB1 Phosphorylation and Deactivation in Lung Cancer by NNAL, a Metabolite of Tobacco-Specific Carcinogen, in an Isomer-Dependent Manner

Nicotine Promotes the Development of Non-Small Cell Lung Cancer Through Activating LINC00460 and PI3K/Akt Signaling

Nicotine-derived NNK induces the stemness enrichment of CRC cells through regulating the balance of DUSP4-ERK1/2 feedback loop

NNK-induced DNA Damage As Measured by the Comet Assay is a Marker of Lung Cancer Risk

Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression

NNK promotes chronic pancreatitis to pancreatic intraepithelial neoplasia and accelerates pancreatic cancer migration

Blockade of Α7 Nicotinic Acetylcholine Receptors Inhibit Nicotine-Induced Tumor Growth and Vimentin Expression in Non-Small Cell Lung Cancer Through MEK/ERK Signaling Way